APAlberto Emilio Panerai

Alberto Emilio Panerai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alberto Emilio Panerai has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Frailty and pain, human studies and animal models

    by Simona D'AGnelli, Giada Amodeo, Silvia Franchi, Benedetta Verduci, Marco Baciarello, Alberto Emilio Panerai, Elena Giovanna Bignami, Paola Sacerdote


  • Open Access

    Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy

    by Giorgia Moschetti, Giada Amodeo, Daniela Maftei, Roberta Lattanzi, Patrizia Procacci, Patrizia Sartori, Gianfranco Balboni, Valentina Onnis, Vincenzo Conte, Alberto Panerai, et al.

    Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomib. The mechanisms underlying this condition are not fully elucidated even if a contribution of neuroinflammation was suggested. Here, we investigated the role of a chemokine family, the prokineticins (PKs), in the development of bortezomib-induced peripheral neuropathy (BIPN), and we used a PK receptor antagonist to counteract the development and progression of the pathology. Neuropathy was induced in male C57BL/6J mice by using a protocol capable to induce a detectable neuropathic phenotype limiting systemic side effects. The presence of allodynia (both mechanical and thermal) and thermal hyperalgesia was monitored over time. Mice were sacrificed at two different time points: 14 and 28 days after the first bortezomib (BTZ) injection. At these times, PK system activation (PK2 and PK-Rs), macrophage and glial activation markers, and cytokine production were evaluated in the main station involved in pain transmission (sciatic nerve, DRG, and spinal cord), and the effect of a PK receptors antagonist (PC1) on the same behavioral and biochemical parameters was assessed. Structural damage of DRG during BTZ treatment and an eventual protective effect of PC1 were also evaluated. BTZ induces in mice a dose-related allodynia and hyperalgesia and a progressive structural damage to the DRG. We observed a precocious increase of macrophage activation markers and unbalance of pro- and anti-inflammatory cytokines in sciatic nerve and DRG together with an upregulation of GFAP in the spinal cord. At higher BTZ cumulative dose PK2 and PK receptors are upregulated in the PNS and in the spinal cord. The therapeutic treatment with the PK-R antagonist PC1 counteracts the development of allodynia and hyperalgesia, ameliorates the structural damage in the PNS, decreases the levels of activated macrophage markers, and prevents full neuroimmune activation in the spinal cord. PK system may be a strategical pharmacological target to counteract BTZ-induced peripheral neuropathy. Blocking PK2 activity reduces progressive BTZ toxicity in the DRG, reducing neuroinflammation and structural damage to DRG, and it may prevent spinal cord sensitization.


  • Open Access

    IL DOLORE, GLI OPPIACEI E I PROBLEMI NEL LORO USO

    by Alberto Panerai

    Several reasons recently lead to a dramatic increase in the use of opiate analgesics all over the world. Italy has always been a Country where opiates were prescribed less than in other Countries, even those incorrectly called “under-developed Countries”. The reason has to be searched in cultural, regulatory (detention, transport) factors, as well in the caution of practitioners for the side effects of opiates or the fear of inducing addiction. Recently rules have become easier also in Italy and here, aswell as abroad, mainly in the United States, the use of opiates has been rapidly increasing. However, the enthusiasm was followed by several serious doubts that are prompting a reversal of this trend. At present, the suggestion is to use opiates, but to pay a lot of attention to when use them and in which patients. Moreover, this “social” caution, was matched by the observation of a number of problems before unknown that make the use of opiates more difficult than it was previously thought.

  • The prokineticin system: an interface between neural inflammation and pain

    by Silvia Franchi, Paola Sacerdote, Alberto Panerai

    Prokineticins (PK) 1 and 2 belong to a new family of chemokines capable to interact with two different G coupled receptors: Prokineticin receptor (PKR)1 and 2. Both prokineticins and their receptors are widely distributed in different tissues and regulate several biological functions. In particular, a role of the PK system in inflammation and nociception has been established. PKRs are expressed in regions of the nervous system associated with pain and in primary sensitive neurons they colocalize with transient potential receptor vanilloid–TRPV1 providing an anatomical interaction in nociceptor sensitization. Moreover, PKs are strongly upregulated in immune and glial cells and sustain a proinflammatory loop in inflamed tissues. Recent evidences indicate that the block of the PK system represents a promising strategy to contrast inflammation and pain.


  • Physiopathology of cephalic pain: where are we?

    by Alberto E. Panerai

    Cephalic pain and psychiatric disease physiopathology is one of the most elusive issues in medical research, and the cause might be common. Going through the possible reasons of the failure in understanding the physiopathology of these diseases might be helpful to project new studies that might overcome the difficulties encountered and thus open a window on cephalic pain and psychiatric disease. New approaches to psychiatric disease might be applied to cephalic pain.


  • Δ9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood

    by Sarah Moretti, Mara Castelli, Silvia Franchi, Maria Augusta Raggi, Laura Mercolini, Michele Protti, Lorenzo Somaini, Alberto E Panerai, Paola Sacerdote

    Marijuana abuse is prominent among adolescents. Although Δ9-THC, one of its main components, has been demonstrated to modulate immunity in adults, little is known about its impact during adolescence on the immune system and the long-lasting effects in adulthood. We demonstrate that 10 days of Δ9-THC treatment induced a similar alteration of macrophage and splenocyte cytokines in adolescent and adult mice. Immediately at the end of chronic Δ9-THC, a decrease of proinflammatory cytokines IL- 1β and TNF-α and an increase of anti-inflammatory cytokine IL-10 production by macrophages were present as protein and mRNA in adolescent and adult mice. In splenocytes, Δ9-THC modulated Th1/Th2 cytokines skewing toward Th2: IFN-γ was reduced, and IL-4 and IL-10 increased. These effects were lost in adult animals, 47 days after the last administration. In contrast, in adult animals treated as adolescents, a perturbation of immune responses, although in an opposite direction, was present. In adults treated as adolescents, a proinflammatory macrophage phenotype was observed (IL-1β and TNF-α were elevated; IL-10 decreased), and the production of Th cytokines was blunted. IgM titers were also reduced. Corticosterone concentrations indicate a long-lasting dysregulation of HPA in adolescent mice. We measured blood concentrations of Δ9-THC and its metabolites, showing that Δ9-THC plasma levels in our mice are in the order of those achieved in human heavy smokers. Our data demonstrate that Δ9-THC in adolescent mice triggers immune dysfunctions that last long after the end of abuse, switching the murine immune system to proinflammatory status in adulthood.


  • Is migraine a disorder of the central nervous system?

    by Alberto E. Panerai

    The chicken and the egg problem is how, in Italian or in English, some time ago one would have referred to a question as the one to be approached here: “Is migraine a disorder of the central nervous system?” or of the peripheral nervous system? Till some time ago, even an honest basic scientist or clinician could almost equally sustain one or the other origin and find data that substantiate her/his opinion. Nowadays, however, our improved knowledge is pushing in the direction of the central nervous system, although many mechanisms remain unclear. The confusion originates from the important role played by multiple and important bidirectional interactions between the peripheral and the central nervous systems, i.e., the trigeminovascular system and the cerebral cortex. The problems are: Who starts first? Who is not working properly? It appears now that the answer to the question has to be probably searched in the delicate balance present in the central nervous system between excitatory and inhibitory circuits, their adaptation to chronic stimuli and, within these circuits, the balance of neurotransmitters, neuromodulators, transporters and ion channels that keeps them well functioning.


  • Corrigendum to “Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy” [Pain 153 (4) (2012) 850–861]

    by Silvia Franchi, Anna E. Valsecchi, Elisa Borsani, Patrizia Procacci, Daniela Ferrari, Cristina Zalfa, Patrizia Sartori, Luigi F. Rodella, Angelo Vescovi, Sabatino Maione, et al.

  • Pain stress and headache

    by Alberto E. Panerai

    The association between pain and stress is an old one, but still it is not really clear who comes first. Pain induces stress, and stress induces pain. Pain is part of our homeostatic system and in this way is an emotion, i.e., it tells us that something is out-of-order (control), and emotion drives our behavior and one behavior is stress response. Stress comes from ourselves: the imagination we have or would like to have of us, from the image others give of us, from the goals we assume it is necessary to reach for our well-being or the goals others want us to fulfill. Stress comes from our social condition and the condition we would like, stress comes from dangerous situations we cannot control. Headache easily fits in the picture.


  • Pain emotion and homeostasis

    by Alberto E. Panerai

    Pain has always been considered as part of a defensive strategy, whose specific role is to signal an immediate, active danger. This definition partially fits acute pain, but certainly not chronic pain, that is maintained also in the absence of an active noxa or danger and that nowadays is considered a disease by itself. Moreover, acute pain is not only an automatic alerting system, but its severity and characteristics can change depending on the surrounding environment. The affective, emotional components of pain have been and are the object of extensive attention and research by psychologists, philosophers, physiologists and also pharmacologists. Pain itself can be considered to share the same genesis as emotions and as a specific emotion in contributing to the maintenance of the homeostasis of each unique subject. Interestingly, this role of pain reaches its maximal development in the human; some even argue that it is specific for the human primate.